Drug Profile
Interleukin-6 fusion toxin
Alternative Names: IL-6PE4E; Interleukin-6 Pseudomonas exotoxin fusion protein; Sigosix®Latest Information Update: 01 Mar 2000
Price :
$50
*
At a glance
- Originator Merck Serono
- Developer Nonindustrial source
- Class Antineoplastics; Interleukins
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myeloid leukaemia
Most Recent Events
- 01 Mar 2000 Discontinued-Preclinical for Myeloid leukaemia in Netherlands (Unknown route)
- 01 Mar 2000 Discontinued-Preclinical for Myeloid leukaemia in USA (Unknown route)
- 25 Jan 1999 No-Development-Reported for Myeloid leukaemia in USA (Unknown route)